Insider · CIK 0001238403
Daniel K Spiegelman
Files at: VTVT, MAZE, BMRN, CASC, RLYP. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 AFForm 4 → | Mar 5, 8:08 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 13,117 | $94.76 | $86,421 | 62,538 | — | plan? |
| Oct 31, 2018 AForm 4 → | Dec 20, 6:06 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 175 | $68.78 | $12,037 | 51,245 | — | plan? late |
| Jun 22, 2018 SForm 4 → | Jun 26, 8:31 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 10,000 | $99.00 | $990,005 | 51,070 | −16.4% | plan? |
| Apr 30, 2018 AFForm 4 → | Jun 6, 8:15 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,878 | $90.00 | $169,018 | 61,070 | — | plan? late |
| Apr 23, 2018 SForm 4 → | Apr 25, 8:37 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 11,059 | $82.15 | $908,497 | 62,543 | −15.0% | plan? |
| Mar 22, 2018 FForm 4/A → | Apr 27, 7:32 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 3,598 | $81.36 | $292,733 | 73,587 | — | plan? |
| Mar 22, 2018 FForm 4 → | Mar 26, 8:08 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 3,583 | $81.36 | $291,513 | 73,602 | — | plan? amended |
| Mar 15, 2018 AFForm 4 → | Mar 19, 9:45 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 16,295 | $83.57 | $318,820 | 77,185 | — | plan? |
| Mar 9, 2018 UForm 4 → | Mar 13, 6:07 pm EDT | Cascadian Therapeutics, Inc.CASC | 21,006 | — | — | 0 | — | plan? |
| Mar 2, 2018 FForm 4 → | Mar 6, 8:48 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 1,609 | $79.86 | $128,495 | 68,520 | — | plan? |
| Feb 26, 2018 AForm 4/A → | Apr 26, 9:04 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 12,615 | — | — | 70,215 | — | plan? |
| Feb 26, 2018 AForm 4 → | Feb 28, 8:57 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 12,529 | — | — | 70,129 | — | plan? amended |
| Oct 31, 2017 AForm 5 → | Feb 14, 2018, 8:23 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 162 | $69.78 | $11,304 | 57,600 | — | plan? |
| Sep 24, 2017 FMForm 4 → | Sep 26, 5:22 pm EDT | Cascadian Therapeutics, Inc.CASC | 2,969 | $3.94 | $2,340 | 21,006 | — | plan? |
| Jun 24, 2017 FMForm 4 → | Jun 27, 5:41 pm EDT | Cascadian Therapeutics, Inc.CASC | 11,323 | $3.78 | $8,562 | 19,225 | — | plan? |
| Jun 12, 2017 FMForm 4 → | Jun 13, 4:42 pm EDT | Cascadian Therapeutics, Inc.CASC | 2,685 | $3.34 | $1,794 | 12,432 | — | plan? |
| Jun 2, 2017 FForm 4 → | Jun 6, 9:07 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,801 | $90.72 | $163,387 | 23,303 | — | plan? |
| Apr 28, 2017 AFForm 4 → | May 17, 6:50 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,877 | $89.75 | $168,460 | 25,104 | — | plan? late |
| Mar 22, 2017 AForm 4 → | Mar 24, 6:41 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 12,200 | — | — | 26,671 | — | plan? |
| Mar 16, 2017 SForm 4 → | Mar 17, 6:30 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,989 | $91.96 | $182,908 | 14,471 | −12.1% | plan? |
| Mar 15, 2017 FForm 4 → | Mar 17, 6:30 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 4,301 | $92.50 | $397,843 | 16,460 | — | plan? |
| Mar 6, 2017 SForm 4 → | Mar 8, 7:28 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 2,303 | $93.32 | $214,916 | 20,761 | −9.99% | plan? |
| Mar 3, 2017 FForm 4 → | Mar 7, 6:38 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 2,283 | $93.95 | $214,488 | 23,064 | — | plan? |
| Feb 28, 2017 SForm 4 → | Mar 2, 6:20 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 35,000 | $94.07 | $3,292,500 | 25,347 | −58.0% | plan? |
| Feb 28, 2017 MForm 4 → | Mar 2, 6:20 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 30,000 | $63.10 | $1,893,000 | 60,347 | — | plan? |
| Feb 24, 2017 AForm 4 → | Feb 28, 4:51 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 12,247 | — | — | 30,347 | — | plan? |
| Jan 9, 2017 SForm 4 → | Jan 10, 4:50 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 5,000 | $90.00 | $450,000 | 18,100 | −21.6% | plan? |
| Nov 9, 2016 SForm 4 → | Nov 14, 2:02 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 20,000 | $90.61 | $1,812,206 | 23,100 | −46.4% | plan? late |
| Oct 31, 2016 AForm 4 → | Nov 14, 2:02 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 156 | $68.44 | $10,677 | 43,100 | — | plan? late |
| Sep 1, 2016 DUForm 4 → | Sep 2, 12:38 pm EDT | Relypsa IncRLYP | 3,487 | $32.00 | $111,584 | 0 | — | plan? |
| Aug 1, 2016 SForm 4 → | Aug 3, 10:19 am EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 4,000 | $99.33 | $397,320 | 42,944 | −8.52% | plan? |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:52 pm EDT | Relypsa IncRLYP | 2,250 | — | — | 3,487 | — | plan? |
| Jun 7, 2016 SForm 4 → | Jun 8, 5:22 pm EDT | Relypsa IncRLYP | 1,013 | $19.31 | $19,562 | 1,237 | −45.0% | plan? |
| Jun 6, 2016 FMForm 5 → | Feb 10, 2017, 4:42 pm EST | Cascadian Therapeutics, Inc.CASC | 3,404 | $7.38 | $5,026 | 10,821 | — | plan? |
| Jun 6, 2016 SForm 4 → | Jun 8, 8:39 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,649 | $89.14 | $146,992 | 46,944 | −3.39% | plan? |
| Jun 3, 2016 FForm 4 → | Jun 7, 11:00 am EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,801 | $90.00 | $162,090 | 48,593 | — | plan? |
| May 31, 2016 SForm 4 → | Jun 2, 6:21 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 20,841 | $89.88 | $1,873,126 | 50,394 | −29.3% | plan? amended |
| May 31, 2016 MForm 4 → | Jun 2, 6:21 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 16,896 | $39.06 | $659,958 | 71,235 | — | plan? amended |
| May 27, 2016 FForm 4 → | May 31, 6:56 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 4,305 | $89.09 | $383,532 | 54,339 | — | plan? |
| May 23, 2016 SForm 4 → | May 25, 2:57 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 3,769 | $87.07 | $328,184 | 58,644 | −6.04% | plan? |
| Apr 29, 2016 AFForm 4 → | May 17, 3:12 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,924 | $79.41 | $152,782 | 62,413 | — | plan? late |
| Mar 15, 2016 AForm 4 → | Mar 17, 5:26 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 16,640 | — | — | 63,933 | — | plan? |
| Mar 3, 2016 FForm 4 → | Mar 7, 8:46 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 2,395 | $89.57 | $214,520 | 47,293 | — | plan? |
| Mar 2, 2016 SForm 4 → | Mar 2, 8:37 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 4,623 | $86.12 | $398,120 | 49,688 | −8.51% | plan? |
| Feb 29, 2016 FForm 4 → | Mar 2, 8:37 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 46,766 | $81.87 | $3,828,732 | 54,311 | — | plan? |
| Feb 24, 2016 AForm 4 → | Feb 26, 5:44 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 72,633 | — | — | 101,077 | — | plan? |
| Nov 16, 2015 SForm 4 → | Nov 18, 4:03 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 20,000 | $104.30 | $2,085,918 | 28,229 | −41.5% | plan? |
| Nov 16, 2015 MForm 4 → | Nov 18, 4:03 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 20,000 | $39.06 | $781,200 | 48,229 | — | plan? |
| Oct 31, 2015 AForm 5 → | Feb 12, 2016, 5:33 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 215 | $51.26 | $11,022 | 28,444 | — | plan? |
| Jun 13, 2015 FMForm 4 → | Jun 16, 5:00 pm EDT | Oncothyreon Inc.ONTY | 20,053 | $3.88 | $15,563 | 52,675 | — | plan? |
| Jun 5, 2015 SForm 4 → | Jun 8, 6:09 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,649 | $122.30 | $201,669 | 28,229 | −5.52% | plan? |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:55 pm EDT | Relypsa IncRLYP | 2,250 | — | — | 2,250 | — | plan? |
| Jun 4, 2015 FForm 4 → | Jun 8, 6:09 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 1,801 | $120.46 | $216,948 | 29,878 | — | plan? |
| May 29, 2015 SForm 4 → | Jun 3, 8:27 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 5,523 | $124.73 | $688,876 | 31,679 | −14.8% | plan? late |
| May 29, 2015 FForm 4 → | Jun 3, 8:27 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 4,305 | $125.57 | $540,579 | 37,202 | — | plan? late |
| May 27, 2015 SForm 4/A → | Oct 13, 2017, 8:43 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 34,078 | $130.00 | $4,430,140 | 75,585 | −31.1% | plan? |
| May 27, 2015 MForm 4/A → | Oct 13, 2017, 8:43 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 34,078 | $67.81 | $2,310,829 | 109,663 | — | plan? |
| May 18, 2015 SForm 4 → | May 28, 5:10 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 34,078 | $130.00 | $4,430,140 | 41,507 | −45.1% | plan? late amended |
| Apr 30, 2015 AFSForm 4 → | May 19, 7:25 pm EDT | BIOMARIN PHARMACEUTICAL INCBMRN | 3,869 | $122.21 | $472,843 | 75,585 | — | plan? late |
| Mar 25, 2015 PForm 4/A → | Apr 2, 5:11 pm EDT | Oncothyreon Inc.ONTY | 20,000 | $1.61 | $32,127 | 40,644 | +96.9% | plan? |
| Mar 25, 2015 PForm 4 → | Apr 1, 7:28 pm EDT | Oncothyreon Inc.ONTY | 20,000 | $1.61 | $32,127 | 40,644 | +96.9% | plan? late amended |
| Mar 3, 2015 AForm 4 → | Mar 5, 7:54 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 10,500 | — | — | 79,278 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:48 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 15,500 | $107.00 | $1,658,500 | 68,676 | −18.4% | plan? |
| Mar 2, 2015 MForm 4 → | Mar 4, 7:48 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 15,500 | $39.06 | $605,430 | 84,176 | — | plan? |
| Mar 5, 2014 SForm 4 → | Feb 10, 2015, 12:57 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 41 | $70.61 | $2,895 | 68,733 | −0.06% | plan? late |
| Mar 18, 2013 AForm 4 → | Feb 10, 2015, 12:57 pm EST | BIOMARIN PHARMACEUTICAL INCBMRN | 98 | $64.66 | $6,337 | 68,751 | — | plan? late |